Merck Animal Health Receives Positive Opinion from EU CVMP for Numelvi Tablets for Dogs

Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., has announced that the European Medicines Agency’s Committee for Veterinary Medicinal Products (CVMP) has issued a positive opinion for Numelvi (atinvicitinib) tablets for dogs. This marks an important step toward the availability of Numelvi in the European Union.